Market Rallies with Biotech and Marketing Stocks Leading
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – 2025-06-03
Introduction
On June 3, 2025, the market saw broad-based rallies across small- and mid-cap names, with several stocks more than doubling in value. Heavy volume and outsized percentage gains characterized the session, led by marketing-services and biotech-related issuers. Below is a summary of key movers, overall trends, and notable volume surges.
Key Stock Data
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| NIVF | 1.71 | 3.45 | 43,416,222 | +102.31% |
| MCTR | 4.60 | 32.50 | 28,664,340 | +606.05% |
| KPRX | 2.89 | 3.65 | 11,535,942 | +26.28% |
| REKR | 1.16 | 1.44 | 27,429,743 | +23.62% |
| AREB | 1.29 | 1.57 | 8,527,303 | +21.57% |
| SIG | 69.59 | 75.36 | 1,995,378 | +8.29% |
| REVB | 0.71 | 0.94 | 17,465,084 | +31.84% |
| TRAW | 1.29 | 1.84 | 33,798,227 | +42.54% |
| LYRA | 17.14 | 25.89 | 4,214,078 | +51.04% |
| KIDZ | 3.17 | 5.36 | 20,961,570 | +68.85% |
| NINE | 0.41 | 0.53 | 1,265,531 | +28.09% |
| BMEA | 1.30 | 2.56 | 49,548,388 | +96.71% |
| RSLS | 3.67 | 6.08 | 35,594,101 | +65.80% |
| HCAI | 0.53 | 1.57 | 2,546,524 | +195.77% |
| SBET | 31.12 | 52.04 | 6,225,116 | +67.28% |
| AGAE | 2.44 | 3.30 | 412,807 | +35.08% |
| VG | 11.92 | 14.40 | 11,188,947 | +20.80% |
| HOLO | 3.47 | 5.24 | 13,892,659 | +50.79% |
| RAY | 0.68 | 1.49 | 1,596,808 | +118.71% |
Market Trends & Patterns
- Broad-based Gains: Every tracked ticker finished higher, indicating strong risk appetite in speculative and growth-oriented names.
- Volume Leadership: Biotech and small-cap marketing stocks dominated volume charts—BMEA (49.5 M), NIVF (43.4 M), RSLS (35.6 M), TRAW (33.8 M).
- Sector Drivers:
- Marketing & Advertising: MCTR surged 606% on heavy turnover following its IPO news and expansion plans.
- Biotech & Health Services: HCAI (+195.8%), NIVF (+102.3%), BMEA (+96.7%) led the health-related rally amid clinical and strategic updates.
Notable Movers
- MCTR (+606.05%)
Record volume (28.7 M) propelled MCTR after its successful IPO and announcements of regional expansion. - RAY (+118.71%) & HCAI (+195.77%)
Both saw double-digit percentage jumps on corporate developments—director changes for RAY and clinical progress for HCAI. - High-Volume Breakouts
- BMEA traded nearly 50 M shares, rallying on pipeline updates.
- NIVF more than doubled on acquisition news.
TL;DR
- All 19 tracked tickers closed with gains; MCTR led with +606%.
- Heavy volume in biotech and marketing names: BMEA, NIVF, RSLS, TRAW.
- Key catalysts: IPO follow-through, clinical updates, corporate filings.
- Market tone: Risk-on, broad participation in small-cap rallies.